Medical Congresses & Scientific Exchange

The medical field remains one of the most dynamic drivers of the cannabis sector. In 2026, it is important to distinguish between specialised medical cannabis conferences and established medical congresses in which medical cannabis is not the sole focus, but increasingly addressed as a relevant component within specific therapeutic areas, particularly pain and palliative care.

Against this backdrop, a distinction must be made between dedicated medical cannabis congresses and medical conferences where medical cannabis is expected to form part of the programme. This development is particularly significant in light of the ongoing reform discussions surrounding the MedCanG and the continued integration of cannabis-based medicines into routine care.

 

Medical cannabis-specific conferences

One of Germany’s leading conferences dedicated to medical cannabis. The focus is on clinical evidence, new indications, regulatory developments and practical experience from medical and pharmaceutical perspectives.

Specialist event focusing on evidence-based cannabinoid therapies, guideline development and clinical practice.

 

Medical congresses with potential medical cannabis focus areas

A central platform for pain and palliative medicine, where medical cannabis plays an increasingly important role, particularly in chronic pain and palliative care.

Broad scientific programme on palliative care, including current developments in the use of cannabis-based medicines.

 

One of the most important German-language congresses on pain medicine, with growing relevance for cannabinoid-based therapies.

 

Business, Industry & Investor Events

For companies, investors and political stakeholders alike, 2026 will be a decisive year. International and national business events provide space for market analysis, strategic partnerships and regulatory assessment.

Exclusive business format focusing on strategic exchange, market trends and international perspectives within the cannabis industry.

Business event held in Germany’s political centre, with a focus on regulation, market structures and networking among key industry stakeholders.

A leading international business conference for the German cannabis industry and a central platform for exchange between industry, policymakers and investors.

International conference focusing on business models, investment and regulatory frameworks in Europe.

  • CB Expo | 15–17 September 2026 | Dortmund

German trade fair for the cannabis industry, with a focus on industrial players, start-ups and market integration.

  • MJBizCon | 1–4 December 2026 | Las Vegas, USA

The world’s largest cannabis trade show and a key international event for anyone seeking to understand and shape global market developments.

 

Pharmacy- and Supply-Related Events

As medical cannabis continues to gain importance in routine care, pharmacies and pharmaceutical stakeholders are moving further into focus.

  • Expopharm | 15–17 September 2026 | Munich

The leading trade fair for the pharmacy market. Medical cannabis is playing an increasingly prominent role, particularly with regard to supply, patient counselling and distribution.

  • German Pharmacists’ Congress 2026 | held in parallel with Expopharm | Munich

The central professional and political forum for the German pharmacy sector. Resolutions and debates have direct implications for pharmacy practice, including in the field of medical cannabis.

 

Additional events with a recreational & community focus

Numerous events aimed more strongly at recreational consumers and the wider community will also take place in 2026. They reflect the cultural and societal dimension of the sector. These include Cannatrade (29.05.-31.05.2026 in Zurich), Mary Jane Berlin (11–14 June 2026, Berlin), Cannafair (21–23 August 2026, Meerbusch) and Cannafriends (25–27 September 2026, Ilsede).

 

The wide range of events demonstrates that the cannabis industry will remain in motion throughout 2026. Medical innovation, regulatory developments and economic dynamics are increasingly interlinked.

We look forward to continuing to follow these topics over the course of the year and to engaging in conversation with many of you in person at upcoming events.

Anything else?

Do you have specific questions or suggestions for the Cannabis Briefing? Then send us an email to briefing@www.cansativa.de. If you are interested in revolutionising the cannabis industry with us, then stay tuned and follow our briefings!

We wish you a good read!

Best wishes from both of us,

Jakob Sons

Founder & Managing Director Cansativa

Benedikt Sons

Founder & Managing Director Cansativa